Teleflex, a provider of medical technology products to protect against infections, has introduced ArrowEvolution, a chlorhexidine-treated peripherally inserted central catheter (PICC) with Chlorag+ard antimicrobial technology, in the US.
ArrowEvolution PICC provides broad spectrum antimicrobial protection both intra and extraluminally and helps clinicians in accessing a pressure injectable, non-tapered PICC with a proven antimicrobial technology chemically bonded to the surface inside and outside, Teleflex said.
ArrowEvolution PICC is available in an ergonomically designed Maximal Barrier Precautions Tray that supports adherence to widely accepted guidelines.
Teleflex chairman and CEO Jeff Black said that with ArrowEvolution PICC, they have redesigned the PICC with patient safety and comfort and with the chlorhexidine-based technology designed to protect PICC catheter surfaces for at least 30 days from the pathogens that cause central line associated bloodstream infections (CLABSIs).
“We are excited about bringing this new technology option to hospitals striving to improve outcomes and attain and sustain zero CLABSIs, a major contributor to healthcare-acquired infections,” Black said.